Nearwater Capital Markets’s Terns Pharmaceuticals TERN Stock Holding History

Nearwater Capital Markets’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,150,400	Closed	-$113M	–	139
2026 Q1	$113M	Buy	2,150,400 +445,600	+26%	+$18.3M	2.67%	9
2025 Q4	$68.9M	Buy	+1,704,800	New	+$39.4M	1.18%	23

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nearwater Capital Markets's TERN Position: Q2 2026 in Review

Nearwater Capital Markets sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,150,400 shares — an estimated $113M sold.

Nearwater Capital Markets first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $113M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Nearwater Capital Markets reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Nearwater Capital Markets sold 2,150,400 Terns Pharmaceuticals shares in Q2 2026, an estimated $113M.
Nearwater Capital Markets first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Nearwater Capital Markets's Terns Pharmaceuticals position peaked at $113M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Nearwater Capital Markets's 13F filing for Q2 2026, filed 14 Aug 2026.